CD209 and COVID-19: High CD209 expression in the small intestine and adipose tissue, as shown by GTEx analysis, indicates potential primary sites for SARS-CoV-2 infection, and increased expression in lymphoid tissues may underlie lymphocytopenia in COVID-19 patients [31].